MIRA Pharmaceuticals, Inc. (MIRA)

NASDAQ: MIRA · IEX Real-Time Price · USD

0.717

-0.013 (-1.71%)

At close: May 13, 2024, 3:59 PM

0.733

+0.016 (2.16%)

After-hours: May 13, 2024, 7:56 PM EDT

MIRA Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Selling, General & Admin	6.95	4.7	1.47
Research & Development	1.57	2.35	0.68
Operating Expenses	8.53	7.05	2.15
Operating Income	-8.53	-7.05	-2.15
Interest Expense / Income	3.46	0.01	0.02
Pretax Income	-11.98	-7.06	-2.18
Net Income	-11.98	-7.06	-2.18
Shares Outstanding (Basic)	19	18	-
Shares Outstanding (Diluted)	19	18	-
Shares Change	5.69%	-	-
EPS (Basic)	-0.64	-0.40	-
EPS (Diluted)	-0.64	-0.40	-
Free Cash Flow	-4.53	-5.6	-1.38
Free Cash Flow Per Share	-0.24	-0.32	-
EBITDA	-8.53	-7.05	-2.15
EBIT	-8.53	-7.05	-2.15

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).